GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » Shiller PE Ratio

Morepen Laboratories (NSE:MOREPENLAB) Shiller PE Ratio : 41.73 (As of May. 22, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories Shiller PE Ratio?

As of today (2025-05-22), Morepen Laboratories's current share price is ₹65.94. Morepen Laboratories's E10 for the quarter that ended in Mar. 2025 was ₹1.58. Morepen Laboratories's Shiller PE Ratio for today is 41.73.

The historical rank and industry rank for Morepen Laboratories's Shiller PE Ratio or its related term are showing as below:

NSE:MOREPENLAB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 28.09   Med: 40.89   Max: 61.62
Current: 39.73

During the past years, Morepen Laboratories's highest Shiller PE Ratio was 61.62. The lowest was 28.09. And the median was 40.89.

NSE:MOREPENLAB's Shiller PE Ratio is ranked worse than
74.14% of 526 companies
in the Drug Manufacturers industry
Industry Median: 25.185 vs NSE:MOREPENLAB: 39.73

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Morepen Laboratories's adjusted earnings per share data for the three months ended in Mar. 2025 was ₹0.350. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹1.58 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Morepen Laboratories Shiller PE Ratio Historical Data

The historical data trend for Morepen Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories Shiller PE Ratio Chart

Morepen Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 30.27

Morepen Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 36.64 54.22 49.11 30.27

Competitive Comparison of Morepen Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's Shiller PE Ratio falls into.


;
;

Morepen Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Morepen Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=65.94/1.58
=41.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morepen Laboratories's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Morepen Laboratories's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.35/157.5517*157.5517
=0.350

Current CPI (Mar. 2025) = 157.5517.

Morepen Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201003 0.000 65.030 0.000
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201706 0.030 107.109 0.044
201709 0.250 109.021 0.361
201712 0.230 109.404 0.331
201803 0.160 109.786 0.230
201806 0.050 111.317 0.071
201809 0.160 115.142 0.219
201812 0.200 115.142 0.274
201903 0.230 118.202 0.307
201906 0.170 120.880 0.222
201909 0.090 123.175 0.115
201912 0.240 126.235 0.300
202003 0.250 124.705 0.316
202006 0.430 127.000 0.533
202009 0.600 130.118 0.727
202012 0.530 130.889 0.638
202103 0.590 131.771 0.705
202106 0.590 134.084 0.693
202109 0.720 135.847 0.835
202112 0.410 138.161 0.468
202203 0.240 138.822 0.272
202206 0.110 142.347 0.122
202209 0.330 144.661 0.359
202212 0.150 145.763 0.162
202303 0.170 146.865 0.182
202306 0.290 150.280 0.304
202309 0.420 151.492 0.437
202312 0.630 152.924 0.649
202403 0.550 153.035 0.566
202406 0.710 155.789 0.718
202409 0.650 157.882 0.649
202412 0.490 158.323 0.488
202503 0.350 157.552 0.350

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Morepen Laboratories  (NSE:MOREPENLAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Morepen Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories Business Description

Traded in Other Exchanges
Address
Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.

Morepen Laboratories Headlines

No Headlines